Jupiter Research Capital (Asia) Ltd’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
Jupiter Research Capital (Asia) Ltd's PRAX Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Praxis Precision Medicines (PRAX) in Q3 2026, closing a stake of 1,797 shares — an estimated $602K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in PRAX in Q2 2026 and held it in 1 quarter. The position peaked at $602K in Q2 2026. 308 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Praxis Precision Medicines position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 1,797 Praxis Precision Medicines shares in Q3 2026, an estimated $602K.
- Jupiter Research Capital (Asia) Ltd first reported a position in Praxis Precision Medicines in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Praxis Precision Medicines position peaked at $602K in Q2 2026.
- 308 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.